Overview
Nathan Schloemer is an Oncologist practicing medicine in Milwaukee, Wisconsin. He has been practicing medicine for over 18 years.
His clinical expertise encompasses Neurofibromatosis Type 1 (NF1), Ehlers-Danlos Syndrome (EDS), and Neurofibromatosis.
He is actively involved in clinical research, co-authoring 16 peer reviewed articles and participating in 2 clinical trials.
Graduate Year
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- INDEMNITY
- POS
- EPO
- HMO
- POS
- PPO
Locations
8915 W Connell Ave, Milwaukee, WI 53226
Additional Areas of Focus
Dr. Schloemer has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Clinical Cancer Center - Froedtert Hospital
John Charlson is an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Charlson is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, and Undifferentiated Pleomorphic Sarcoma. Dr. Charlson is board certified in Medical Oncology. Dr. Charlson is currently accepting new patients.
Clinical Cancer Center - Froedtert Hospital
Dr. Kurzrock is a world-renowned leader in precision oncology and rare cancers research. She is the Associate Director of Clinical Research for the Medical College of Wisconsin Cancer Center, Associate Director of Precision Oncology at the Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine and the founding director of the Michels Rare Cancers Research Laboratories at the MCW Cancer Center. She is recognized as one of the world’s 25 most important voices in precision medicine and one of the most highly cited scientists globally. She has authored over 950 scientific and medical publications. Dr. Kurzrock is the Chair for the Early Therapeutics and Rare Cancers Committee (SWOG NCI) — one of the largest clinical trials cooperative groups in the country — and has been the principal investigator for more than 100 early-phase clinical trials, leading eight life-changing drugs to FDA approval. In 2022, Dr. Kurzrock and the DART rare cancer study team received the National Cancer Institute Director’s Award of Merit for outstanding work. Dr. Kurzrock is highly rated in 37 conditions, according to our data. Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Castleman Disease, Multicentric Castleman Disease (MCD), Lymphoid Hyperplasia, and Tissue Biopsy. Dr. Kurzrock is board certified in Internal Medicine and Medical Oncology. Dr. Kurzrock is currently accepting new patients.
Froedtert And The Medical College Of Wisconsin Froedtert Hospital
Parameswaran Hari is an Oncologist practicing medicine in Milwaukee, Wisconsin. Dr. Hari is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Primary Amyloidosis, Bone Marrow Transplant, and Splenectomy.
Frequently Asked Questions about Dr. Nathan Schloemer
How do I make an appointment with Dr. Nathan Schloemer?
You can book an appointment with Dr. Nathan Schloemer by calling their office at 414-266-2000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Nathan Schloemer a top-rated expert for Neurofibromatosis Type 1 (NF1)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nathan Schloemer is classified as an Experienced expert for Neurofibromatosis Type 1 (NF1), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Nathan Schloemer specialize in?
While Dr. Nathan Schloemer is a Oncology, they have specific expertise in Neurofibromatosis Type 1 (NF1), Ehlers-Danlos Syndrome (EDS), and Neurofibromatosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Nathan Schloemer participate in research or clinical trials?
Yes. Dr. Nathan Schloemer has published 16 articles and abstracts on conditions like Neurofibromatosis Type 1 (NF1). You can view a list of Dr. Nathan Schloemer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Nathan Schloemer accept my insurance?
Dr. Nathan Schloemer accepts most major insurance plans, including Anthem BCBS and Aspirus Arise Health. We recommend calling the office directly at 414-266-2000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Ehlers-Danlos Syndrome (EDS)Dr. Schloemer isExperienced. Learn about Ehlers-Danlos Syndrome (EDS).
- NeurofibromatosisDr. Schloemer isExperienced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)Dr. Schloemer isExperienced. Learn about Neurofibromatosis Type 1 (NF1).